Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy-Reference-Cited by-同舟云学术

Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy

Published:2021-10-18 Issue:44 Volume:143 Page:18536-18547
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Yin Huawu¹²,Zhou Xiuman³,Huang Yen-Hua¹²^ORCID,King Gordon J.⁴,Collins Brett M.¹,Gao Yanfeng³⁵,Craik David J.¹²^ORCID,Wang Conan K.¹²^ORCID

Affiliation:

1. Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia

2. Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, Queensland 4072, Australia

3. School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China

4. Centre for Microscopy and Microanalysis, The University of Queensland, Brisbane, Queensland 4072, Australia

5. School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China

Funder

National Health and Medical Research Council

Australian Research Council

China Scholarship Council

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/jacs.1c08132

Reference49 articles.

1. Cancer Immunotherapy

2. Programmed Death-1: Therapeutic Success after More than 100 Years of Cancer Immunotherapy

3. Cancer immunotherapy: The past, the present and the future

4. Cancer immunotherapy comes of age

5. Releasing the Brakes on Cancer Immunotherapy

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel bispecific peptide targeting PD-1 and PD-L1 with combined antitumor activity of T-cells derived from the patients with TSCC;International Immunopharmacology;2024-09

2. Miniprotein engineering for inhibition of PD‐1/PD‐L1 interaction;Protein Science;2024-07-16

3. Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice;Cells;2024-07-15

4. De novo design of covalent bonding peptides for target protein;hLife;2024-07

5. Targeted protein editing technique in living mammalian cells by peptide-fused PNGase;hLife;2024-07